SCHAERR JAFFE LLP

Lobbying for CELLPHIRE THERAPEUTICS, INC. · biotechnology company

Filing 4th Quarter - Report

Reporting period

4th Quarter 2025

Oct 1 - Dec 31 · Posted Jan 20, 2026

Money reported

None

Registrations and no-activity reports carry no figure.

Client based in

Maryland

Government bodies contacted 1

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

Lobbying activity 1

Health Issues

Blood platelet technology and the Strategic National Stockpile

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.